Literature DB >> 29788047

Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction.

Masaru Obokata1, Thomas P Olson1, Yogesh N V Reddy1, Vojtech Melenovsky1, Garvan C Kane1, Barry A Borlaug1.   

Abstract

Aims: Increases in left ventricular filling pressure are a fundamental haemodynamic abnormality in heart failure with preserved ejection fraction (HFpEF). However, very little is known regarding how elevated filling pressures cause pulmonary abnormalities or symptoms of dyspnoea. We sought to determine the relationships between simultaneously measured central haemodynamics, symptoms, and lung ventilatory and gas exchange abnormalities during exercise in HFpEF. Methods and results: Subjects with invasively-proven HFpEF (n = 50) and non-cardiac causes of dyspnoea (controls, n = 24) underwent cardiac catheterization at rest and during exercise with simultaneous expired gas analysis. During submaximal (20 W) exercise, subjects with HFpEF displayed higher pulmonary capillary wedge pressures (PCWP) and pulmonary artery pressures, higher Borg perceived dyspnoea scores, and increased ventilatory drive and respiratory rate. At peak exercise, ventilation reserve was reduced in HFpEF compared with controls, with greater dead space ventilation (higher VD/VT). Increasing exercise PCWP was directly correlated with higher perceived dyspnoea scores, lower peak exercise capacity, greater ventilatory drive, worse New York Heart Association (NYHA) functional class, and impaired pulmonary ventilation reserve.
Conclusion: This study provides the first evidence linking altered exercise haemodynamics to pulmonary abnormalities and symptoms of dyspnoea in patients with HFpEF. Further study is required to identify the mechanisms by which haemodynamic derangements affect lung function and symptoms and to test novel therapies targeting exercise haemodynamics in HFpEF.

Entities:  

Mesh:

Year:  2018        PMID: 29788047      PMCID: PMC6658816          DOI: 10.1093/eurheartj/ehy268

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  41 in total

1.  Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities.

Authors:  M J Sullivan; M B Higginbotham; F R Cobb
Journal:  Circulation       Date:  1988-03       Impact factor: 29.690

2.  Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Rick A Nishimura; Paul Sorajja; Carolyn S P Lam; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2010-06-11       Impact factor: 8.790

3.  Lung function and exercise gas exchange in chronic heart failure.

Authors:  K Wasserman; Y Y Zhang; A Gitt; R Belardinelli; A Koike; L Lubarsky; P G Agostoni
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

4.  Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.

Authors:  Muaz M Abudiab; Margaret M Redfield; Vojtech Melenovsky; Thomas P Olson; David A Kass; Bruce D Johnson; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2013-02-20       Impact factor: 15.534

5.  Long-term use of sildenafil in the therapeutic management of heart failure.

Authors:  Marco Guazzi; Michele Samaja; Ross Arena; Marco Vicenzi; Maurizio D Guazzi
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

6.  Influence of locomotor muscle metaboreceptor stimulation on the ventilatory response to exercise in heart failure.

Authors:  Thomas P Olson; Michael J Joyner; Bruce D Johnson
Journal:  Circ Heart Fail       Date:  2010-01-08       Impact factor: 8.790

7.  Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis.

Authors:  Nicholas E Houstis; Aaron S Eisman; Paul P Pappagianopoulos; Luke Wooster; Cole S Bailey; Peter D Wagner; Gregory D Lewis
Journal:  Circulation       Date:  2017-10-09       Impact factor: 29.690

8.  Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.

Authors:  Gregory D Lewis; Ravi V Shah; Paul P Pappagianopolas; David M Systrom; Marc J Semigran
Journal:  Circ Heart Fail       Date:  2008-11       Impact factor: 8.790

9.  Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.

Authors:  Michael R Zile; Barbro Kjellstrom; Tom Bennett; Yong Cho; Catalin F Baicu; Mark F Aaron; William T Abraham; Robert C Bourge; Fred J Kueffer
Journal:  Circ Heart Fail       Date:  2013-03-20       Impact factor: 8.790

10.  Dissociation between exertional symptoms and circulatory function in patients with heart failure.

Authors:  J R Wilson; G Rayos; T K Yeoh; P Gothard; K Bak
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

View more
  48 in total

1.  Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.

Authors:  Barry A Borlaug; Kevin J Anstrom; Gregory D Lewis; Sanjiv J Shah; James A Levine; Gabe A Koepp; Michael M Givertz; G Michael Felker; Martin M LeWinter; Douglas L Mann; Kenneth B Margulies; Andrew L Smith; W H Wilson Tang; David J Whellan; Horng H Chen; Victor G Davila-Roman; Steven McNulty; Patrice Desvigne-Nickens; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

2.  Pericardiotomy Enhances Left Ventricular Diastolic Reserve With Volume Loading in Humans.

Authors:  Barry A Borlaug; Hartzell V Schaff; Alberto Pochettino; Dawn M Pedrotty; Samuel J Asirvatham; Martin D Abel; Rickey E Carter; William J Mauermann
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

Review 3.  The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?

Authors:  Masaru Obokata; Yogesh N V Reddy; Barry A Borlaug
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

Review 4.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

5.  Characterization of the Progression From Ambulatory to Hospitalized Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Aaron D Jones; Gregory D Lewis; Sanjiv J Shah; Omar F Abouezzedine; Marat Fudim; Brooke Alhanti; Lynne W Stevenson; Margaret M Redfield; Barry A Borlaug
Journal:  J Card Fail       Date:  2020-08-19       Impact factor: 5.712

6.  The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Brandon Wiley; Katlyn E Koepp; Caitlin C Jorgenson; Alexander Egbe; Vojtech Melenovsky; Rickey E Carter; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

Review 7.  Performance and Interpretation of Invasive Hemodynamic Exercise Testing.

Authors:  C Charles Jain; Barry A Borlaug
Journal:  Chest       Date:  2020-05-28       Impact factor: 9.410

8.  The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

Authors:  Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Vojtech Melenovsky; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

Review 9.  Diastolic Stress Testing Along the Heart Failure Continuum.

Authors:  T Jake Samuel; Rhys Beaudry; Satyam Sarma; Vlad Zaha; Mark J Haykowsky; Michael D Nelson
Journal:  Curr Heart Fail Rep       Date:  2018-12

10.  Left Atrial Contracture or Failure to Dilate.

Authors:  Masaru Obokata; Yogesh N V Reddy; Jeong Hoon Yang; Brandon M Wiley; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2018-09       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.